Consistently, a role for SPARC has been previously associated to an increase in M2 versus M1 ratio in a murine pancreatic cancer model, suggesting that M1 could also be eliminated in vivo (Arnold et al., 2012). Here, SPARC is linked to pancreatic neoplasm.